多囊肾病患者长期暴露于细颗粒物与肾功能下降的关联
KEY POINTS: Long-term exposure to fine particulate matter was associated with faster decline in kidney function among patients with polycystic kidney disease. Associations were stronger in younger patients and those with preserved kidney function at baseline.…
要点
- 年轻及基线肾功能保留的患者关联更明显。
- 接受托伐普坦治疗的患者中关联较弱。
研究设计与样本
- 基于韩国国民健康信息数据库的回顾性队列研究,纳入18,898名多囊肾病成人,2016至2023年间至少两次健康筛查。
主要发现
- 年轻成人中关联为-0.26(95%CI -0.42至-0.09),基线肾功能保留者为-0.14(95%CI -0.21至-0.07)。
- 男性中关联为-0.10(95%CI -0.21至0),未处方托伐普坦者为-0.12(95%CI -0.20至-0.04)。
临床怎么用
- 在多囊肾病管理中,可考虑环境风险减少策略与药物治疗结合,以延缓ESKD发生。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Long-term exposure to fine particulate matter was associated with faster decline in kidney function among patients with polycystic kidney disease. Associations were stronger in younger patients and those with preserved kidney function at baseline. The association was weaker among patients prescribed tolvaptan. BACKGROUND: Polycystic kidney disease (PKD) is the fourth leading cause of ESKD. Although the condition is primarily genetic, environmental exposures such as air pollution may influence disease progression. METHODS: We investigated whether long-term exposure to fine particulate matter (PM 2 . 5 ) is associated with kidney function decline among individuals with PKD and whether this association differs by age, sex, initial kidney function, and tolvaptan use. Using the Korea National Health Information Database, we identified 18,898 adults with PKD who underwent at least two health screenings between 2016 and 2023. Annual mean PM 2 . 5 exposure was estimated with a high-resolution (1 km 2 ) machine learning-based model. Linear mixed-effects models were applied to assess the association between PM 2 . 5 exposure and changes in eGFR, adjusting for demographic, socioeconomic, and lifestyle covariates. RESULTS: Each 1 µ g/m 3 higher lag 0-1 year PM 2 . 5 was associated with a -0.09 ml/min per 1.73 m 2 change in eGFR (95% confidence interval [CI], -0.16 to -0.01). More evident associations were observed among younger adults (-0.26; 95% CI, -0.42 to -0.09), individuals with preserved baseline kidney function (-0.14; 95% CI, -0.21 to -0.07), male (-0.10; 95% CI, -0.21 to 0), and individuals who were not prescribed tolvaptan (-0.12; 95% CI, -0.20 to -0.04). CONCLUSIONS: Chronic exposure to PM 2 . 5 appears to be an environmental modifier of kidney function decline in PKD, particularly among younger individuals and those with preserved kidney function. Environmental risk reduction strategies, together with pharmacologic therapy, may help delay the onset of ESKD in this vulnerable population.
引用
- Kwag Y, Min J, Lee W, et al. Long-Term Exposure to Fine Particulate Matter and Kidney Function among Patients with Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2026. PMID: 41979893. doi:10.2215/CJN.0000001065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。